the aid library

LIST OPTIONS

Filter

3295

Children’s Palliative Care and Human Rights

Open Society Foundation (2015) C1

Palliative care for children with life-limiting illness is the active total care of the child’s body, mind, and spirit. It begins at diagnosis and continues regardless of whether the child receives treatment directed at the disease. It seeks to control all forms of suffering related to the illness... more

Download (124)

View PDF (159)

Guidelines for HIV and AIDS diagnosis and treatment

Ministry of Health (2009) C2

(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)

Download (491)

View PDF (536)

Including Children with Disabilities in Humanitarian Action - Child protection

United Nations Children's Fund (UNICEF) (2017)

Guidance | Preparedness - Response and early recovery - Recovery and reconstruction

Download (107)

View PDF (144)

Adolescents with HIV

Dr. C. D. Kalombo The Southern African HIV Clinicians Society (SAHCS) (2019) C2

Specific Issues and a Model of Care Accessed; 08.10.2019

Download (200)

View PDF (433)

Including children with disabilities in humanitarian action - Education

United Nations Children's Fund (UNICEF) (2017)

Guidance | Preparedness - Response and early recovery - Recovery and reconstruction

Download (209)

View PDF (359)

Human rights for women and children wit disabilities

Human Rights Watch (2011) C1

Barriers to Full Realization of Human Rights for Women and Children with Disabilities

Download (150)

View PDF (178)

HIV/AIDS + Work - A handbook on HIV/AIDS for labour and factory inspector

nternational Labour Organization International Labour Organization (2005) C2

This handbook aims to help labour inspectors deal with the issue of HIV/AIDS. It establishes the links between the key principles and core responsibilities of labour inspectorates and the management of HIV/ AIDS at the workplace. It includes training activities and practical tools to help inspecto... more

Download (138)

View PDF (140)

Faith sector response to hiv and aids in kenya action plan 2015/2016-2019/2020

Ministry of Health, Kenya; National AIDS Control Council (2015) C1

The National AIDS Control Council (NACC) continues to strengthen partnerships with all stakeholders in the response to HIV and AIDS in Kenya. While recognizing that there is no single preventive approach to reverse the spread of HIV, the faith sector comprising of Faith Communities (FCs) a... more

Download (1102)

View PDF (382)

BEST PRACTICES IN INCLUSIVE EDUCATION FOR CHILDREN WITH DISABILITIES

Lynn Losert USAIDE&E (2010) C2

Application for Program Design in the Europe and Eurasia Region

Download (273)

View PDF (339)

National Guidelines for Prevention and Management of HIV, STIs & Other Blood Borne Infections

Ministry of Health, Rwanda & Rwanda Biomedical Centre (2013) C2

These are integrated National Guidelines 2013 for Prevention and Management of HIV, STIs & Other Blood Borne Infections in accordance with the last guidelines of the World Health Organization (WHO) published in June 2013 and adapted to the Rwandan national context. It thus responds to the need by th... more

Download (99)

View PDF (104)

Abuja Declaration on HIV/AIDS, Tuberculosis, and Other Infectious Diseases

African Union (AU) African Union (AU) (2001) CC

The Abuja declaration identifies that the prevention and control of HIV/AIDS, tuberculosis and related infectious diseases must come with additional financial resources. Therefore, African governments agreed on setting the target of allocating at least 15 per cent of each country’s annual budget ... more

Download (1109)

View PDF (1985)

Compendium of Gender Equality and HIV Indicators

Shelah S. Bloom and Svetlana Negroustoueva MEASURE Evaluation (2013)

The intended purpose of this compendium is to provide program managers, organizations, and policy makers with a menu of indicators to better “know their HIV epidemic/know their response” from a gender perspective. The indicators in the compendium are all either part of existing indicators used i... more

External Link

Adolescent HIV Care and Treatment: A Training Curriculum for Health Workers (Zambia) Trainer Manual

ICAP; CDC; University Teaching Hospital,; Ministry of Health, Zambia, et al. (2011) C1

A Training Curriculum for Multidisciplinary Healthcare Teams. This innovative training package aims to empower multidisciplinary health workers to have the confidence and skills to provide comprehensive, youth-friendly HIV services that support adolescents’ healthy development, psychosocial well b... more

External Link

Uptake of HIV testing in Burkina Faso: an assessment of individual and community level determinants

Kirakoya-Samadoulougou F., K. Jean, M. Maheu-Giroux BMC Public Health (2017) C2

Previous studies have highlighted a range of individual determinants associated with HIV testing but few have assessed the role of contextual factors. The objective of this paper is to examine the influence of both individual and community-level determinants of HIV testing uptake in Burkina Faso.

Download (284)

View PDF (380)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (107)

View PDF (136)

USAID/Senegal HIV/AIDS and Tuberculosis programs interim assessment

Dione D., L. Toure, G. Maynard-Tucker United States Agency for International Development (2010) C2

The goal of this assessment is to determine how far USAID/Senegal’s HIV/AIDS and TB programs have achieved their specific objectives with regard to identifying potential leads for improvement that are likely to make it easier to reach the planned results. After responding to the issues developed i... more